Journal Article

FZJ-2024-03652

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs)

Schmitt, L. ; Hoppe, J. ; Cea-Medina, P. ; Bruch, P.-M. ; Krings, K. S. ; Lechtenberg, I. ; Drießen, D. ; Peter, C. ; Bhatia, S. ; Dietrich, S. ; Stork, B. ; Fritz, G. ; Gohlke, H.FZJ* ; Müller, T. J. J. ; Wesselborg, S. (Corresponding author)

2024
Nature Publishing Group London

This record in other databases:    

Please use a persistent id in citations: doi:10.1038/s41420-024-02056-6  doi:10.34734/FZJ-2024-03652

---

Contributing Institute(s):

1. Bioinformatik (IBG-4)

Research Program(s):

1. 2171 - Biological and environmental resources for sustainable use (POF4-217) (POF4-217)
2. GRK 2158 - Graduiertenkolleg 2158 – Naturstoffe und Analoga gegen Therapie-resistente Tumoren und Mikroorganismen: Neue Leitstrukturen und Wirkmechanismen (GRK-2158-20170406) (GRK-2158-20170406)

Appears in the scientific report 2024

---

Database coverage:
; ; ; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---